# Efgartigimod: First Approval

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/efgartigimod-first-approval/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Young‐A Heo |
| Citations | 165 |
| DOI | 10.1007/s40265-022-01678-3 |
| Fields | Medicine |
| Open Access | true |
| OA Status | hybrid |
| OA URL | https://link.springer.com/content/pdf/10.1007/s40265-022-01678-3.pdf |
| OpenAlex ID | https://openalex.org/W4212956148 |
| PMID | 35179720 |
| Type | article |
| Year | 2022 |

## Paper authors

- [Young‐A Heo](https://scholariq.org/researchers/young-a-heo/)

## Paper journal

- [Drugs](https://scholariq.org/journals/drugs/)

## Paper primary topic

- [Myasthenia Gravis and Thymoma](https://scholariq.org/topics/myasthenia-gravis-and-thymoma/)

## Paper topics

- [Myasthenia Gravis and Thymoma](https://scholariq.org/topics/myasthenia-gravis-and-thymoma/)
- [Antifungal resistance and susceptibility](https://scholariq.org/topics/antifungal-resistance-and-susceptibility/)
- [Autoimmune Bullous Skin Diseases](https://scholariq.org/topics/autoimmune-bullous-skin-diseases/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.